ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 292 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q4 2019. The put-call ratio across all filers is 1.07 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $162 | -59.2% | 4 | -66.7% | 0.00% | – |
| Q3 2022 | $397 | -50.1% | 12 | 0.0% | 0.00% | – |
| Q4 2021 | $796 | -44.7% | 12 | -76.0% | 0.00% | -100.0% |
| Q1 2020 | $1,439 | -84.9% | 50 | -66.7% | 0.00% | -80.0% |
| Q4 2019 | $9,515 | -79.1% | 150 | -90.7% | 0.01% | -80.0% |
| Q3 2019 | $45,567 | +6.3% | 1,617 | 0.0% | 0.02% | 0.0% |
| Q2 2019 | $42,851 | – | 1,617 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Western Financial Corp/CA | 820,320 | $20,836,128 | 14.83% |
| Aquilo Capital Management, LLC | 1,018,474 | $25,869,240 | 10.72% |
| Rokos Capital Management LLP | 1,675,921 | $41,537,702 | 3.07% |
| COMMODORE CAPITAL LP | 575,000 | $14,605,000 | 2.22% |
| Privium Fund Management B.V. | 259,036 | $6,579,514 | 2.21% |
| JOHNSON & JOHNSON | 247,598 | $6,288,989 | 2.05% |
| WEALTH EFFECTS LLC | 156,810 | $3,982,976 | 2.04% |
| M28 Capital Management LP | 67,400 | $1,711,960 | 1.94% |
| Evolutionary Tree Capital Management, LLC | 51,878 | $1,317,701 | 1.83% |
| Avidity Partners Management LP | 1,741,300 | $44,229,020 | 1.47% |